Myeloproliferative neoplasia and JAK2-mutation

被引:4
作者
Almedal, Henry [1 ]
Vorland, Marta [2 ]
Aarsand, Aasne K. [2 ,3 ]
Gronningsaeter, Ida-Sofie [4 ,5 ]
Bruserud, Oystein [4 ,5 ]
Reikvam, Hakon [6 ]
机构
[1] Univ Bergen, Med Odontol Fak, Bergen, Norway
[2] Haukeland Univ Sjukehus, Lab Klin Biokjemi, Bergen, Norway
[3] Haraldsplass Diakonale Sykehus, Norsk Kvalitetsforbedring Lab Virksomhet Utentor, Bergen, Norway
[4] Haukeland Univ Sjukehus, Med Avdeling, Bergen, Norway
[5] Univ Bergen, Med Odontol Fak, Klin Inst 2, Bergen, Norway
[6] Haraldsplass Diakonale Sykehus, Med Avdeling, Bergen, Norway
关键词
D O I
10.4045/tidsskr.16.0128
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1889 / 1894
页数:6
相关论文
共 31 条
  • [1] Epidemiology of MPN: What Do We Know?
    Anderson, L. A.
    McMullin, M. F.
    [J]. CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2014, 9 (04) : 340 - 349
  • [2] The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
    Arber, Daniel A.
    Orazi, Attilio
    Hasserjian, Robert
    Thiele, Jurgen
    Borowitz, Michael J.
    Le Beau, Michelle M.
    Bloomfield, Clara D.
    Cazzola, Mario
    Vardiman, James W.
    [J]. BLOOD, 2016, 127 (20) : 2391 - 2405
  • [3] Rationale for revision and proposed changes of the WHO diagnostic criteria for polycythemia vera, essential thrombocythemia and primary myelofibrosis
    Barbui, T.
    Thiele, J.
    Vannucchi, A. M.
    Tefferi, A.
    [J]. BLOOD CANCER JOURNAL, 2015, 5 : e337 - e337
  • [4] Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
    Baxter, EJ
    Scott, LM
    Campbell, PJ
    East, C
    Fourouclas, N
    Swanton, S
    Vassiliou, GS
    Bench, AJ
    Boyd, EM
    Curtin, N
    Scott, MA
    Erber, WN
    Green, AR
    [J]. LANCET, 2005, 365 (9464) : 1054 - 1061
  • [5] Berentsen S, 2015, INDREMEDISINEREN, V1, P16
  • [6] The JAK2 V617F mutational status and allele burden may be related with the risk of venous thromboembolic events in patients with Philadelphia-negative myeloproliferative neoplasms
    Borowczyk, Martyna
    Wojtaszewska, Marzena
    Lewandowski, Krzysztof
    Gil, Lidia
    Lewandowska, Maria
    Lehmann-Kopydlowska, Agata
    Kroll-Balcerzak, Renata
    Balcerzak, Andrzej
    Iwola, Malgorzata
    Michalak, Michal
    Komarnicki, Mieczyslaw
    [J]. THROMBOSIS RESEARCH, 2015, 135 (02) : 272 - 280
  • [7] Geetha J P, 2010, J Lab Physicians, V2, P114, DOI 10.4103/0974-2727.72215
  • [8] Ghanima Waleed, 2013, Tidsskr Nor Laegeforen, V133, P1946, DOI 10.4045/tidsskr.12.1106
  • [9] Helsedirektoratet, 2016, NASJ HANDL MED RETN
  • [10] A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
    James, C
    Ugo, V
    Le Couédic, JP
    Staerk, J
    Delhommeau, F
    Lacout, C
    Garçon, L
    Raslova, H
    Berger, R
    Bennaceur-Griscelli, A
    Villeval, JL
    Constantinescu, SN
    Casadevall, N
    Vainchenker, W
    [J]. NATURE, 2005, 434 (7037) : 1144 - 1148